Vanta Bioscience announced its standalone and consolidated financial results for the half year ended on September 30, 2019 showing a rise in revenue and profit margins

Company : Vivid Mercantile Ltd

Vanta Bioscience Limited recently released its HY1 financials for FY2019-20 marking Rs.28.19 lacs rise in standalone net profit as compared to a year ago peiod.

Following are the standalone HY1 financials at Vanta Bioscience for FY2019-20:

- Revenue reached Rs.7.30 crore whereas last year same period it was Rs.6.09 crore.

- PBT was Rs.78.75 lacs as compared to Rs.45.83 lacs in the corresponding period a year ago.

- Net profit stood at Rs.57.49 lacs against Rs.29.30 lacs in a year ago period.

- EPS was Rs.0.91 while in the same period preceding year it was Rs.0.51

Following are the consolidated HY1 financial figures of FY2019-20 at Vanta Bioscience:

- Total revenue earned is Rs.7.33 crore while the same period last year it was Rs.6.09 crore.

- Net profit reached Rs.54.40 lacs against Rs.29.30 lacs in a year ago period.

- Earnings per share stood at Rs.0.86 where as last year corresponding period it was Rs.0.51

The total consolidated earnings at Vanta Biosciencein the financial year 2018-19 was Rs.12.71 crore and profit after tax was Rs.69.66 lacs.

Recent Stories